NCT04128839

Brief Summary

The overall goal of this project is to determine the inflammation lowering impact of anthocyanin-rich Aronia berries. Inflammation is an underlying mechanism driving the development of several diseases. While an elevation in immune signals in the systemic circulation is commonly attributed to adipose tissue, inflammation is not present in all obese individuals. Adipose tissue must become inflamed, and the inflammation trigger may come from other sources. Microorganisms (microbiome), host tissues, and immune cells residing in the gastrointestinal tract (GIT) are a key source of pro-inflammatory signals that may cause the host organism to become inflamed. Anthocyanins are bioactive compounds with established anti-inflammatory and microbiome altering properties. We hypothesize that the GIT microbiome is a key determinant of host inflammation than can be manipulated by anthocyanins-rich berries to lower inflammation. We assembled a cohort of individuals, characterized their GIT microbiome and performed anthropometric measurements, basal measures of metabolism and metabolic health, and triglyceridemic, metabolomic, and inflammation responses to a high-fat meal challenge.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 27, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

October 14, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 16, 2019

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 27, 2021

Completed
Last Updated

January 16, 2024

Status Verified

January 1, 2024

Enrollment Period

5 months

First QC Date

October 14, 2019

Last Update Submit

January 12, 2024

Conditions

Keywords

gut microbiomemetabolomepostprandial hypertriglyceridemialow-grade inflammationvisceral adipose tissue

Outcome Measures

Primary Outcomes (18)

  • Inflammation state

    Serum levels of a eight cytokine panel: interleukin (IL)-1B, IL-6, IL-10, IL-17, IL-23, tumor necrosis factor-alpha (TNF-a), granulocyte macrophage-colony stimulating factor (GM-CSF), interferon gamma (IFNy)

    1 day

  • Gut microbiome

    Taxonomic composition of the gut microbiome measured from 16s rRNA sequencing of stool samples

    1 day

  • Gut Metabolome

    Stool sample metabolome

    1 day

  • Postprandial TG Response to a High-fat Meal Challenge

    TG concentrations before, 1, 2, 4, and 6 hours following consumption of a meal containing 50 g of fat (toast with butter)

    1 day

  • Postprandial Inflammation Response to a High-fat Meal Challenge

    Cytokine panel (IL-1B, IL-6, IL-10, IL-17, IL-23, TNF-a, GM-CSF, and IFNy) before, 1, 2, 4, and 6 hours following consumption of a meal containing 50 g of fat (toast with butter)

    1 day

  • Postprandial Metabolomic Response to a High-fat Meal Challenge

    Serum metabolome before, 1, 2, 4, and 6 hours following consumption of a meal containing 50 g of fat (toast with butter)

    1 day

  • Glycemic control

    Hemoglobin A1c (% glycosylation)

    1 day

  • Fasting glucose

    Fasting serum glucose (mM)

    1 day

  • Fasting insulin

    Fasting serum insulin (pmol/l)

    1 day

  • Lipid panel

    Fasting serum TG, LDL, HDL, and total cholesterol

    1 day

  • Fasting metabolites

    Serum metabolome measured after an overnight fast

    1 day

  • Self-reported physical activity

    Self report of the number of days each week in which aerobic, strength, and stretching type exercises are performed

    1 day

  • Blood pressure

    Resting systolic and diastolic blood pressure (mmHg)

    1 day

  • Body composition

    Body composition (% fat, %lean)

    1 day

  • Height

    Height (m)

    1 day

  • Weight

    Weight (kg)

    1 day

  • Waist circumference

    Waist circumference (cm)

    1 day

  • Visceral adipose tissue

    Volume of visceral adipose tissue (l)

    1 day

Study Arms (2)

Aronia juice (ARO)

EXPERIMENTAL

A juice blend of three different cultivars was used: Viking, MacKenzie and Autumn Magic. Raw juice was heat pasteurized before provided to participants. Participants consumed 100 mL of juice per day for duration of intervention period (28-30 days)

Dietary Supplement: Aronia berry juice

Placebo juice (PLA)

SHAM COMPARATOR

The placebo juice was flavor, color, and carbohydrate-matched to experimental Aronia juice. PLA consisted of 28.8 g black cherry Koolaid mix (no sugar added), 128.5 g sorbitol, 74.5 g glucose, 77.9 g fructose, 4 oz lemon juice, 16 drops of blue food coloring, and enough water to create 1 L of solution. Participants consumed 100 mL of juice per day for duration of intervention period (28-30 days)

Other: Sham comparator

Interventions

Aronia berry juiceDIETARY_SUPPLEMENT

A juice blend of three different cultivars was used: Viking, MacKenzie and Autumn Magic. Raw juice was heat pasteurized before provided to participants. Participants consumed 100 mL of juice per day.

Aronia juice (ARO)

The placebo was flavor, color, and carbohydrate-matched to aronia juice. The placebo consisted of 28.8 g black cherry Koolaid mix (no sugar added), 128.5 g sorbitol, 74.5 g glucose, 77.9 g fructose, 4 oz lemon juice, 16 drops of blue food coloring, and enough water to create 1 L of solution. Participants consumed 100 mL of juice per day.

Placebo juice (PLA)

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI 28-35 kg/m\^2

You may not qualify if:

  • Antibiotics up to 90 days prior to enrollment
  • Anti-inflammatory medications
  • Allergy or intolerance to wheat or dairy
  • Hormone-based birth control (with exception of intrauterine device)
  • Pregnant
  • Heart disease
  • Other health conditions or concerns that may interfere with study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montana State University

Bozeman, Montana, 59717, United States

Location

Related Publications (1)

  • Wilson SM, Maes AP, Yeoman CJ, Walk ST, Miles MP. Determinants of the postprandial triglyceride response to a high-fat meal in healthy overweight and obese adults. Lipids Health Dis. 2021 Sep 20;20(1):107. doi: 10.1186/s12944-021-01543-4.

MeSH Terms

Conditions

Metabolic SyndromeInflammationHypertriglyceridemiaObesity

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsHyperlipidemiasDyslipidemiasLipid Metabolism DisordersOverweightOvernutritionNutrition DisordersBody WeightSigns and Symptoms

Study Officials

  • Mary P Miles, PhD

    Montana State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Placebo (PLA) was flavor, color, and carbohydrate matched to intervention treatment of Aronia juice. PLA consisted of 28.8 g black cherry Koolaid mix (no sugar added), 128.5 g sorbitol, 74.5 g glucose, 77.9 g fructose, 4 oz lemon juice, 16 drops of blue food coloring, and enough water to create 1 L of solution. Participants consumed 100 mL/ day.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2019

First Posted

October 16, 2019

Study Start

April 27, 2019

Primary Completion

September 30, 2019

Study Completion

December 27, 2021

Last Updated

January 16, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations